Artificial Intelligence (AI) in Medical Imaging Market worth $4.54 billion by 2029

 The global AI medical imaging market, valued at US$1.29 billion in 2023, is forecasted to grow at a robust CAGR of 22.4%, reaching US$1.65 billion in 2024 and an impressive US$4.54 billion by 2029. The factors driving the market growth include increasing government initiatives on AI-based technologies, higher funding for AI startups, a massive inflow of big data, and growing cross-industry collaborations. The market offers significant opportunities, particularly in untapped emerging markets such as Latin America, Southeast Asia, and Africa, where expanding healthcare infrastructure creates demand for cost-effective, AI-powered diagnostic solutions. Furthermore, a focus on developing human-aware AI systems that align with clinician decision-making and provide interpretable, patient-centered insights is immense to foster trust and adoption in medical settings. AI’s capability to enhance early detection, automate imaging workflows, and integrate with advanced imaging modalities positions it as a transformative force in improving diagnostic accuracy and healthcare outcomes globally.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21977207

Global AI in Medical Imaging Market Dynamics
DRIVER: Increasing Growing demand for AI-based solutions to reduce work pressure on radiologists
The medical imaging industry has rapidly embraced AI technologies due to their transformative potential, revolutionizing imaging processes and improving clinical outcomes. AI automates routine tasks and enables radiologists to focus more on improved patient care. The rising shortage of radiologists drives the increasing demand for AI-based solutions in radiology; the estimates indicate that there has been a need for almost 42,000 additional radiologists in the US by 2033.

RESTRAINT: Inadequate AI workforce and ambiguous regulatory guidelines for medical software
The deployment of AI in healthcare faces significant challenges due to a scarcity of competent experts and ambiguous regulations. Creating and integrating AI systems in healthcare settings necessitates skills in advanced domains such as cognitive computing, ML, deep learning, and image analysis. The complexity of these technologies necessitates precise data processing to imitate human brain operations, and even tiny errors might result in failures or undesirable effects. However, the lack of skilled specialists and standardized AI credentials impedes growth, which hampers the sector’s overall development. Furthermore, the regulation of medical AI software is inconsistent and imprecise. Rapid advances in AI technology make it challenging for regulators to develop and maintain current norms.

OPPORTUNITY: Growth opportunities in untapped emerging markets
The growing patient population and developing healthcare infrastructure in emerging nations such as China, India, and Brazil present substantial growth prospects for AI-based medical imaging. For example, the NIH and Family Welfare in India estimates that there are between 2 and 2.5 million cancer patients at any given time, with about 700,000 new cases recorded each year. Similarly, the healthcare industries in emerging economies such as China and India have evolved quickly due to the uptake of cutting-edge medical technology, especially in sophisticated imaging equipment. Medical imaging data is increasing due to this expansion, opening up new possibilities for AI-driven imaging.

CHALLENGES: Reluctance to embrace AI-based technologies among physicians
With AI technology providing tools that improve diagnosis and patient care, the quick development of digital health allowed healthcare practitioners to embrace novel treatment modalities. Still, there is a noticeable hesitancy among physicians to adopt these developments. Many medical professionals believe that human traits such as empathy and persuasion cannot be recreated by technology, which leads them to assume that AI will eventually replace doctors. Long-term doctor-patient interactions may be strained if patients grow unduly dependent on AI tools and perhaps neglect essential in-person sessions. Furthermore, medical experts doubt AI systems’ ability to identify illnesses accurately.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=21977207

North America held the largest market share in 2023.
In 2023, North America accounted for the largest share of the global AI in medical imaging market. The shortage of radiologists in the region has created a huge demand for AI-based imaging tools that can assist or even replace human radiologists in tasks such as the interpretation of medical images. AI solutions can significantly improve efficiency, reduce the workload on healthcare professionals, and help bridge this gap. The region has also experienced an increase in chronic diseases, further fueling the demand for advanced diagnostic tools to improve patient outcomes. A strong research environment in North America, along with increased funding for studies regarding the ethical utilization of AI in imaging tools, also propels the use of AI in healthcare activities. There has been a development and a very high level of investment in the health infrastructure of this region, coupled with a high amount of investment in AI-driven technology that supports the rapid acceleration of AI solutions in the field of medical imaging. These factors collectively contribute to North America’s dominant position in the global AI in medical imaging market.

Recent Developments of AI in Medical Imaging Market
-Partnership: In July 2024, Microsoft partnered with Mass General Brigham and the University of Wisconsin to enhance AI models for medical imaging, improving radiologist efficiency and patient outcomes.
-Collaboration: In March 2024, Microsoft (US) collaborated with NVIDIA(US) to combine Azure’s cloud and AI capabilities with NVIDIA’s DGX cloud and Clara suite to accelerate innovations in medical imaging, diagnosis, and patient care
-Collaboration: In July 2024, GE Healthcare collaborated with AWS to create AI-driven healthcare models, optimizing workflows and boosting diagnostic accuracy.
-Partnership: In November 2023, NVIDIA Corporation (US) partnered with the National Health Research Institute (Taiwan) to leverage accelerated computing and AI for advancing biomedical research by adopting NVIDI’s powerful Blackwell platform, which enables complex data analysis and supports applications ranging from medical imaging to drug discovery and personalized medicine.